Pulsenmore stock up as at-home ultrasound secures FDA de novo authorisation
Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug Administration (FDA). Pulsenmore ES enables pregnant women to perform guided scans at home that are subsequently interpreted by remote …